We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-7.65%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$271B
AUM Growth
-$17.9B
Cap. Flow
+$8.75B
Cap. Flow %
3.23%
Top 10 Hldgs %
15.47%
Holding
7,097
New
161
Increased
2,856
Reduced
3,285
Closed
377

Sector Composition

Rank Sector Weight
1 Healthcare 9.07%
2 Financials 8.9%
3 Technology 7.48%
4 Consumer Discretionary 7.12%
5 Communication Services 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XTLB
6551
XTL Biopharmaceuticals
XTLB
$6.83M
0
YHGJ icon
6552
Yunhong Green CTI Ltd
YHGJ
$7.75M
-1
Closed
AIFC
6553
AI Financial Corp
AIFC
$54.3M
-2
Closed
XYLO
6554
DELISTED
Xylo Technologies
XYLO
0
AIOT
6555
PowerFleet Inc
AIOT
$519M
-22,944
Closed -$140K
QCLS
6556
Q/C Technologies Inc
QCLS
$20.3M
0
CSCI
6557
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
0
ORKA
6558
Oruka Therapeutics
ORKA
$5.71B
0
GRCE
6559
Grace Therapeutics
GRCE
$33.4M
0
JXG
6560
JX Luxventure
JXG
0
QVCGB
6561
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
-1
Closed -$2K
TGEN
6562
Tecogen Inc
TGEN
$96.9M
-28
Closed
VOXX
6563
DELISTED
VOXX International Corporation Class A
VOXX
$0 ﹤0.01%
2
-8,038
-100% -$63.4K
WHLM
6564
DELISTED
Wilhelmina International, Inc
WHLM
$0 ﹤0.01%
15
-11
-42% -$64
BYU
6565
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
-1
Closed -$1K
ENSV
6566
DELISTED
Enservco Corp.
ENSV
-4,549
Closed -$102K
HMNF
6567
DELISTED
HMN Financial Inc
HMNF
-9
Closed
BIMI
6568
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
0
DYNT
6569
DELISTED
Dynatronics Corp
DYNT
-1
Closed
CTHR
6570
DELISTED
Charles & Colvard Ltd
CTHR
$0 ﹤0.01%
59
-4
-6% -$55
NURO
6571
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
0
MARK
6572
DELISTED
Remark Holdings, Inc.
MARK
-2
Closed
MDVL
6573
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
0
BETS
6574
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
AEY
6575
DELISTED
ADDvantage Technologies Group
AEY
-2
Closed

Similar funds

Morgan Stanley's Q3 2015 Portfolio in Review

As of Q3 2015, Morgan Stanley held 7,097 positions worth $271B, down 6.2% from $289B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley deployed $8.75B of net new capital in Q3 2015, opening 161 new positions and adding to 2,856 existing holdings. Its largest new stake was Kraft Heinz: 7,552,361 shares worth $533M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 11% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $1.44B trimmed.

  • Morgan Stanley's largest Q3 2015 buy was Kraft Heinz: 7,552,361 shares worth $533M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $10.5B increase.
  • Morgan Stanley's biggest Q3 2015 reduction was AbbVie, cutting an estimated $1.44B.
  • Morgan Stanley fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $458M.
  • Morgan Stanley's ten largest holdings make up 15% of its $271B portfolio in Q3 2015.
  • Morgan Stanley opened 161 new positions and closed 377 in Q3 2015.
  • Morgan Stanley's portfolio value fell 6.2% quarter-over-quarter to $271B.

Based on Morgan Stanley's 13F filing for Q3 2015, filed 9 Nov 2015.